Mutations in TUBB4A are associated with a spectrum of neurologic disorders categorized as TUBB4A-related leukoencephalopathy. Affected children can present with global developmental delay or normal early development, followed by a variable loss of skills over time. Further research is needed to characterize the factors associated with the divergent developmental trajectories in this rare monogenic disorder because this phenotypic spectrum is not fully explained by genotype alone.

To characterize early psychomotor features, developmental milestones and age of disease onset were collected from medical records (n=54 individuals). Three subcohorts were identified: individuals with the common p.Asp249Asn variant vs all other genotypes with either early (<12 months of age) or late onset of presentation. Individuals with the p.Asp249Asn variant or those with non-p.Asp249Asn genotypes with later disease onset attained key milestones, including head control, sitting, and independent walking. Subjects with early-onset, non-p.Asp249Asn–associated disease were less likely to achieve developmental milestones. Next, we defined the developmental severity as the percentage of milestones attained by age 2 years. The mild form was defined as attaining at least 75% of key developmental milestones. Among cohort categorized as mild, individuals with p.Asp249Asn variant were more likely to lose acquired abilities when compared with non-p.Asp249Asn individuals.

Our results suggest multiple influences on developmental trajectory, including a strong contribution from genotype and age of onset. Further studies are needed to identify additional factors that influence overall outcomes to better counsel families and to design clinical trials with appropriate clinical endpoints.

1. Breuss, M, Keays, DA. Microtubules and neurodevelopmental disease: the movers and the makers. Adv Exp Med Biol. 2014;800:75–96.
Google Scholar | Crossref | Medline2. Nogales, E, Whittaker, M, Milligan, RA, Downing, KH. High-resolution model of the microtubule. Cell. 1999. 96(1):79–88.
Google Scholar | Crossref | Medline3. Romaniello, R., Arrigoni, F, Fry, AE, et al. Tubulin genes and malformations of cortical development. Eur J Med Genet. 2018;61(12):744–754.
Google Scholar | Crossref | Medline4. Breuss, MW, Leca, I, Gstrein, T, Hansen, AH, Keays, DA. Tubulins and brain development—the origins of functional specification. Mol Cell Neurosci. 2017;84:58–67.
Google Scholar | Crossref | Medline5. Simons, C, Wolf, NI, McNeil, N, et al. A de novo mutation in the beta-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum. Am J Hum Genet. 2013;92(5):767–773.
Google Scholar | Crossref | Medline6. Curiel, J, Bey, GR, Takanohashi, A, et al. TUBB4A mutations result in specific neuronal and oligodendrocytic defects that closely match clinically distinct phenotypes. Hum Mol Genet. 2017;26(22):4506–4518.
Google Scholar | Crossref | Medline7. Duncan, ID, Bugiani, M, Radcliff, AB, et al. A mutation in the Tubb4a gene leads to microtubule accumulation with hypomyelination and demyelination. Ann Neurol. 2017;81(5):690–702.
Google Scholar | Crossref | Medline8. Nahhas, N, Conant, A, Hamilton, E, et al. TUBB4A-Related leukodystrophy. In: Adam, MP, Ardinger, HH, Pagon, RA, et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; November 3, 2016.
Google Scholar9. Blumkin, L, Halevy, A, Ben-Ami-Raichman, D, et al. Expansion of the spectrum of TUBB4A-related disorders: a new phenotype associated with a novel mutation in the TUBB4A gene. Neurogenetics. 2014;15(2):107–113.
Google Scholar | Medline10. Pizzino, A, Pierson, TM, Guo, Y, et al. TUBB4A de novo mutations cause isolated hypomyelination. Neurology, 2014;83(10):898–902.
Google Scholar | Crossref | Medline11. Alexoudi, A, Schneider, SA. De novo mutations in the beta-tubulin gene TUBB4: from DYT4 to leukoencephalopathy with hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC syndrome). Mov Disord. 2013;28(10):1343.
Google Scholar | Crossref | Medline12. Erro, R, Hersheson, J, Ganos, C, et al. H-ABC syndrome and DYT4: variable expressivity or pleiotropy of TUBB4 mutations? Mov Disord. 2015;30(6):828–833.
Google Scholar | Crossref | Medline13. Hersheson, J, Mencacci, NE, Davis, M, et al. Mutations in the autoregulatory domain of beta-tubulin 4a cause hereditary dystonia. Ann Neurol. 2013;73(4):546–553.
Google Scholar | Crossref | Medline14. Lohmann, K, Wilcox, RA, Winkler, S, et al. Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene. Ann Neurol. 2013;73(4):537–545.
Google Scholar | Crossref | Medline15. Lu, Y, Ondo, Y, Shimojima, Osaka, H, Yamamoto, T. A novel TUBB4A mutation G96 R identified in a patient with hypomyelinating leukodystrophy onset beyond adolescence. Hum Genome Var. 2017;4:17035.
Google Scholar | Crossref | Medline16. Leandro-Garcia, LJ, Leskelä, S, Landa, I, et al. Tumoral and tissue-specific expression of the major human beta-tubulin isotypes. Cytoskeleton (Hoboken). 2010;67(4):214–223.
Google Scholar | Crossref | Medline17. Vulinovic, F, Krajka, V, Hausrat, TJ, et al. Motor protein binding and mitochondrial transport are altered by pathogenic TUBB4A variants. Hum Mutat. 2018;39(12):1901–1915.
Google Scholar | Crossref | Medline18. Adang, L, Gavazzi, F, Simone, MD, et al. Developmental outcomes of Aicardi Goutières syndrome. J Child Neurol. 2020;35:7–16.
Google Scholar | SAGE Journals | ISI19. Hamilton, EM, Polder, E, Vanderver, A, et al. Hypomyelination with atrophy of the basal ganglia and cerebellum: further delineation of the phenotype and genotype-phenotype correlation, Brain. 2014;137(7):1921–1930.
Google Scholar | Crossref | Medline